Sygnature Discovery Elevates its Global Stature with Major North American Acquisition
Key Takeaways Sygnature Discovery boosts its global growth by acquiring NuChem Sciences, a leading North American Contract Research Organisation (CRO). The acquisition solidifies Sygnature’s position as one of the world’s largest players in integrated drug discovery phase solutions. Following this acquisition, Sygnature